Palatin Technologies
PTN
#10067
Rank
NZ$64.39 M
Marketcap
NZ$36.34
Share price
-3.24%
Change (1 day)
10,193.89%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -NZ$8.39 Million

According to Palatin Technologies's latest financial reports the company's current earnings are NZ$8.84 Million. In 2024 the company made an earning of -NZ$45.53 Million, an increase over its 2023 earnings that were of -NZ$54.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$8.39 Million-81.58%
2024 -NZ$45.53 Million-16.9%
2023 -NZ$54.79 Million5.99%
2022 -NZ$51.7 Million-13.7%
2021 -NZ$59.9 Million33.25%
2020 -NZ$44.95 Million-172.11%
2019 NZ$62.33 M2352.33%
2018 NZ$2.54 M-94.13%
2017 NZ$43.31 M-154.92%
2016 -NZ$78.86 Million3.67%
2015 -NZ$76.07 Million878%
2014 -NZ$7.78 Million-72.64%
2013 -NZ$28.43 Million-33.11%
2012 -NZ$42.5 Million77.71%
2011 -NZ$23.92 Million
2003 -NZ$40.5 Million29.93%
2002 -NZ$31.17 Million36.18%
2001 -NZ$22.89 Million
1999 -NZ$19 Million6.04%
1998 -NZ$17.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$56.70 B-699,817.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$23.84 B-294,318.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
NZ$1.07 B-13,374.02%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-NZ$20.29 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.27 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.2 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$85.42 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-NZ$49.84 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-NZ$93.88 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA